Preliminary reports indicate conolidine might inhibit specific ion channels, decreasing neuronal excitability and limiting discomfort alerts. This system is particularly appropriate in neuropathic discomfort, wherever irregular signaling causes persistent discomfort. Additionally, conolidine seems to impact G protein-coupled receptor (GPCR) pathway